Walgreens’ Healthcare Clinics to enhance care coordination among providers
DEERFIELD, Ill. – Walgreens on Thursday announced its Healthcare Clinics will soon transition to the Epic electronic health record platform, to further enhance care coordination among providers, while also supporting the long-term growth plan for its clinic business.
The move to the new EHR, EpicCare, will begin in early calendar year 2016.
“This state-of-the-industry EHR will enable more seamless communication with health systems and local providers, and gives us enhanced capabilities to deliver better health outcomes through greater care coordination and interoperability,” stated Patrick Carroll,chief medical officer for Healthcare Clinics. "As our clinics play an increasingly important role in health care, supporting the health care system, provider practices and patients’ medical homes, care coordination can be critical. This will benefit our patients, clinic providers and partners, and serves as an instrumental part of our strategic growth plan.”
The platform will provide a number of benefits, including Care Everywhere – Epic’s EHR-based interoperability network. The largest in the U.S., it will connect with other healthcare organizations to securely share a patient’s medication list, assisting with medication reconciliation and review during Healthcare Clinic visits.
“As we continue to invest in our retail clinic business, it’s critical to have these best-in-class intelligence tools that support our commitment to patient care, and can help position Healthcare Clinics as a strategic partner of choice within the communities we serve,” said Jeff Koziel, group VP for Walgreens Healthcare Clinics.
Walgreens manages more than 400 Healthcare Clinic locations in the U.S., and currently utilizes its own proprietary EHR.
Less than half of diabetics identify with increased risk of eye disease
TARRYTOWN, N.Y. – Less than half of U.S. adults with diabetes recognize their risk for vision loss, according to a survey released Thursday by Regeneron Pharmaceuticals. In fact, less than 18% of respondents said they were familiar with diabetic macular edema, a term that refers to swelling of the macula and is a complication of diabetic retinopathy, the most common diabetic eye disease.
The survey found that nearly one third (30%) of respondents reported they do not get an annual comprehensive dilated eye exam, a test that can help to detect DME and diabetic retinopathy. Of those respondents who do not get an annual dilated eye exam, more than half (56%) were not aware that the exam is recommended by the National Eye Institute for people with diabetes or that it could help protect against vision loss associated with the disease.
"Getting an annual comprehensive dilated eye exam is a critical step that may help to prevent future vision loss by identifying issues early," stated Allen Ho, director of Retina Research, Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University. "These survey findings underscore the need for more awareness among the diabetes community about their risk for vision loss and what they can do help protect their vision."
Additional findings from the online survey of 1,074 people living with diabetes include:
- When thinking about diabetes complications, those surveyed said eye disease is the No. 2 concern, behind cardiovascular disease;
- Despite concerns, however, less than half (44%) of respondents said they were very knowledgeable about eye diseases that could result in vision loss; and
- Only one third (35%) of respondents said they were familiar with diabetic retinopathy, specifically.
In an effort to create awareness and dialogue about improved eye care for people living with diabetes, Regeneron launched a new online resource, www.DiabetesSightRisk.com, which offers information about diabetic eye diseases including facts and symptoms, as well as details around comprehensive dilated eye exams.
In addition, the company has teamed up with Intelligent Retinal Imaging Systems on a month-long national initiative called the 30/30 Campaign. Through this program, IRIS will hold 30 or more diabetic retinopathy screening events across the United States during Diabetes Awareness Month this November.
These findings are part of a survey conducted by the Market Research Group at Everyday Health on behalf of Regeneron.
Loading Post Please Wait...